Charles River Laboratories (CRL) Q3 Earnings and Revenues Surpass Estimates

Charles River Laboratories (CRL) came out with quarterly earnings of $2.43 per share, beating the Zacks Consensus Estimate of$ 2.32 per share. This compares to earnings of $2.59 per share a year ago. These figures are adjusted for non-recurring items.This quarterly report represents an earnings surprise of +4.74%. A quarter ago, it was expected that this medical research equipment and services provider would post earnings of$ 2.5 per share when it actually produced earnings of $3.12, delivering a surprise o ...